More than 40 patients have been treated using the system, according to Varian.
In other company news, Varian has signed an agreement with Bank of America to repurchase $280 million of its common stock under an accelerated share repurchase program. Under the deal, Varian will pay $280 million to Bank of America and receive approximately 3.5 million shares (85% of the shares to be repurchased) based on the closing share price of the company's common stock on February 23.
The total number of shares to be repurchased will be determined upon final settlement. Varian will receive additional shares of common stock or under certain circumstances be required to remit a settlement amount payable at Varian's option in cash or common stock. The amount would be based generally on the volume-weighted average share price of the company's common stock during the next two to six months.
Related Reading
Varian adapts Aria to support NHS, February 1, 2011
Varian wins German proton therapy contract, December 14, 2010
Varian installs linac in Bulgaria, November 30, 2010
Vision RT signs on Varian, October 25, 2010
Varian reports first Italian treatments, October 13, 2010
Copyright © 2011 AuntMinnieEurope.com